Hexarelin

Also known as: Examorelin

Overview

Hexarelin is a synthetic hexapeptide GHRP that potently stimulates growth hormone release via GHS-R1a. It produces one of the strongest GH pulses in its class and also exhibits cardioprotective effects, including reduced oxidative stress and improved lipid profiles. Long-term use may induce desensitization and elevate cortisol and prolactin. Hexarelin is the strongest GHRP.

Benefits

- Enhanced cardioprotection

- Muscle support

- Better lipid profile

- Growth hormone boost

Consider This Peptide If You Want To

- Stimulate GH for muscle growth, fat loss, and recovery

- Improve cardiovascular health and protect against oxidative stress

Dosage & Administration

Dosage Guidelines

Recommended Dosage

• Amount:100 mcg

• Frequency:weekdays

• Duration:8 weeks

• Rest Period:8 weeks

• Time of Day:morning

• Ingestion:subcutaneous

Administration Routes:Subcutaneous

Research Findings on Dosage:

• Subcutaneous Injection:

◦ Commonly Reported Dosage: 100 mcg, multiple injections can be given daily, 5 day on, 2 days off

◦ Duration: 4-8 weeks on, 4-8 weeks off

• Administration Notes:

◦ Administer on an empty stomach 30 minutes before eating/2 hours after eating to enhance GH release.

Mechanism of Action

Mechanism of Action

How this peptide works in the body

Hexarelin binds to growth hormone secretagogue receptor 1a (GHS-R1a) in the anterior pituitary and hypothalamus, stimulating the release of growth hormone (GH). This activation triggers the cyclic AMP (cAMP) and phospholipase C (PLC) pathways, leading to the release of GH from somatotroph cells. As a result, insulin-like growth factor-1 (IGF-1) production in the liver increases, promoting muscle growth, fat metabolism, and cellular regeneration.

Cardioprotective Action:

Hexarelin reduces oxidative stress by enhancing mitochondrial superoxide dismutase (SOD) activity, which neutralizes free radicals and prevents cardiomyocyte damage. Additionally, it activates the Akt/PI3K signaling pathway, preventing cardiomyocyte apoptosis and preserving heart function. By enhancing nitric oxide (NO) production, Hexarelin improves endothelial function, vasodilation, and overall cardiac output.

Cholesterol and Lipid Regulation:

Hexarelin modulates liver enzyme activity involved in lipid metabolism, reducing triglyceride accumulation and improving cholesterol balance. By activating peroxisome proliferator-activated receptor alpha (PPAR-α), it enhances lipid oxidation and fat metabolism, supporting cardiovascular health and reducing atherosclerosis risk.

Muscle Preservation:

Hexarelin stimulates myogenesis by activating the mechanistic target of rapamycin (mTOR) pathway, promoting muscle protein synthesis and hypertrophy. It also inhibits myostatin, a negative regulator of muscle growth, allowing for greater skeletal muscle repair and regeneration.

Hexarelin stimulates myogenesis by activating the mechanistic target of rapamycin (mTOR) pathway, promoting muscle protein synthesis and hypertrophy. It also inhibits myostatin, a negative regulator of muscle growth, allowing for greater skeletal muscle repair and regeneration.

Consider Stacking With

- Any GHRH (CJC-1295, MOD-GRF-1295, Tesamorelin)

- BPC-157

- TB-4

- AOD-9604

- Semaglutide/Tirzepatide

- PEG-MGF

- Kisspeptin-10

- 5-Amino-1MQ

Side Effects & Cautions

Common Side Effects

- Injection site redness, itchiness, swelling

- Increased appetite (less than GHRP-2/6)

- Water retention

- Desensitization with prolonged use

- Mild edema

Cautions

- Avoid with hormone-sensitive conditions (e.g., prolactinomas)

- Use caution in cardiovascular disease pending further research

Research & References

Research Highlights

Cardiac Protection (2002): Hexarelin reduced cardiac fibrosis and apoptosis in animal models post-heart attack. (Source: PMID 12473550)

Lipid Metabolism (2001): Improved cholesterol profiles and reduced triglyceride levels in clinical trials. (Source: PMID 11522130)

References

Hexarelin in Muscle Wasting Conditions - Published: 2011 (PMID 22005308)

Hexarelin and GH Secretion Dynamics - Published: 1999 (PMID 10211492)

Cardioprotective Effects of Hexarelin - Published: 2002 (PMID 12473550)

Hexarelin in Muscle Wasting Conditions - Published: 2011 (PMID 22005308)

Impact of Hexarelin on Lipid Metabolism - Published: 2001 (PMID 11522130)

Hexarelin and GH Secretion Dynamics - Published: 1999 (PMID 10211492)